Abstract
Resveratrol (3,4,5'-trihydroxy-trans-stilibene) is a famous natural product which exhibits potential antitumor activity both in vitro and in vivo. In this article, A series of formamide derivatives of resveratrol (C1-27) were synthesized and their cytotoxic activities were evaluated, with results indicating that most of the compounds exhibited antitumor activity against both Smmc7721 and SGC7901 cancer cell lines. Among them, compound C21 displayed the most potent antitumor activities, with IC50 values of 7.68 and 6.16 M against Smmc7721 and SGC7901 cancer cell lines respectively. All compounds reported herein were characterized by 1H NMR, 13C NMR, MS and IR spectrum. Additionally, the structure of compound C10 was confirmed by X-ray crystallographic analysis.
Keywords: Resveratrol, formamide derivatives, synthesis, characterization, single-crystal x-ray diffraction, antitumor activity.
Letters in Drug Design & Discovery
Title:Formamide Derivatives of Resveratrol: Synthesis, Characterization and Cytotoxicity
Volume: 13 Issue: 6
Author(s): Hai-Jun Ni, Hui-Jie Cheng, Wei-Wei Ge, Meng-Xue Lin, Qing-Shan Li and Ban-Feng Ruan
Affiliation:
Keywords: Resveratrol, formamide derivatives, synthesis, characterization, single-crystal x-ray diffraction, antitumor activity.
Abstract: Resveratrol (3,4,5'-trihydroxy-trans-stilibene) is a famous natural product which exhibits potential antitumor activity both in vitro and in vivo. In this article, A series of formamide derivatives of resveratrol (C1-27) were synthesized and their cytotoxic activities were evaluated, with results indicating that most of the compounds exhibited antitumor activity against both Smmc7721 and SGC7901 cancer cell lines. Among them, compound C21 displayed the most potent antitumor activities, with IC50 values of 7.68 and 6.16 M against Smmc7721 and SGC7901 cancer cell lines respectively. All compounds reported herein were characterized by 1H NMR, 13C NMR, MS and IR spectrum. Additionally, the structure of compound C10 was confirmed by X-ray crystallographic analysis.
Export Options
About this article
Cite this article as:
Ni Hai-Jun, Cheng Hui-Jie, Ge Wei-Wei, Lin Meng-Xue, Li Qing-Shan and Ruan Ban-Feng, Formamide Derivatives of Resveratrol: Synthesis, Characterization and Cytotoxicity, Letters in Drug Design & Discovery 2016; 13 (6) . https://dx.doi.org/10.2174/157018081306160618153304
DOI https://dx.doi.org/10.2174/157018081306160618153304 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multi-Targeted Natural Products Evaluation Based on Biological Activity Prediction with PASS
Current Pharmaceutical Design Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Current Pharmaceutical Design Antitumor Activity of Benzamide Riboside In Vitro and In Vivo
Current Medicinal Chemistry Sanguinarine: A Double-Edged Sword of Anticancer and Carcinogenesis and Its Future Application Prospect
Anti-Cancer Agents in Medicinal Chemistry Modified-Release Solid Formulations for Colonic Delivery
Recent Patents on Drug Delivery & Formulation Inhibition of Bacterial Carbonic Anhydrases and Zinc Proteases: From Orphan Targets to Innovative New Antibiotic Drugs
Current Medicinal Chemistry Pyrimidine Nucleosides in Molecular PET Imaging of Tumor Proliferation
Current Medicinal Chemistry Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms
Endocrine, Metabolic & Immune Disorders - Drug Targets SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer
Current Cancer Drug Targets Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
Current Neuropharmacology The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology Structural Biology of Bacterial Secretion Systems in Gram-Negative Pathogens- Potential for New Drug Targets
Infectious Disorders - Drug Targets The Pim Kinases: New Targets for Drug Development
Current Drug Targets Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer
Current Drug Targets Utilizing Ultrasound to Transiently Increase Blood-Brain Barrier Permeability, Modulate of the Tight Junction Proteins, and Alter Cytoskeletal Structure
Current Neurovascular Research Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Clinical Cancer Drugs